Fulvia Orsini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fulvia Orsini has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
- Guido Sello
Department of Chemistry, University of Milano, Via Golgi 19, 20133 Milan, Italy
32 shared publications F. Pelizzoni
Dipartimento di Chimica Organica e Industriale, Università degli Studi di Milano, via Venezian 21, 20133 Milano, Italy, Istituto di Chimica e Biochimica “G. Ronzoni”, via G. Colombo 81, 20133 Milano, Italy, and Department of Chemistry, University Durban-Westville, Private Bag X54001, Durban 4000, Republic of South Africa
21 shared publicationsFrancesca Pelizzoni
16 shared publications- Luisella Verotta
Department of Environmental Science and Policy, Università degli Studi di Milano, Via Celoria 2, 20133 Milano, Italy
16 shared publications Patrizia Di Gennaro
Dipartimento di Scienze dell’Ambiente e del Territorio, Universita’ di Milano-Bicocca, p.za della Scienza 1, 20126 Milano, Italy
10 shared publicationsSilvana Bernasconi
Dipartimento di Chimica Organica e Industriale, Universita’ degli Studi di Milano, via Venezian 21, 20133 Milano, Italy
10 shared publications
Latest Publications
- 4 April 2018
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 9 (5) , 843-852
Synthesis and biological evaluation of new 3-amino-2-azetidinone derivatives as anti-colorectal cancer agents
Several synthetic combretastatin A4 (CA-4) derivatives were recently prepared to increase the drug efficacy and stability of the natural product isolated from the South African tree Combretum caffrum. A group of ten 3-amino-2-azetidinone derivatives, as combretastatin A4 analogues, was selected through docking experiments, synthesized and tested for their anti-proliferative activity against the colon cancer SW48 cell line. These molecules, through the formation of amide bonds in position 3, allow the synthesis of various derivatives that can modulate the activity with great resistance to hydrolytic conditions. The cyclization to obtain the 3-aminoazetidinone ring is highly diastereoselective and provides a trans biologically active isomer under mild reaction conditions with better yields than the 3-hydroxy-2-azetidinone synthesis. All compounds showed IC50 values ranging between 14.0 and 564.2 nM, and the most active compound showed inhibitory activity against tubulin polymerization in vitro, being a potential therapeutic agent against colon cancer.
- 4 April 2018
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 9 (5) , 843-852
Synthesis and biological evaluation of new 3-amino-2-azetidinone derivatives as anti-colorectal cancer agents
Several synthetic combretastatin A4 (CA-4) derivatives were recently prepared to increase the drug efficacy and stability of the natural product isolated from the South African tree Combretum caffrum. A group of ten 3-amino-2-azetidinone derivatives, as combretastatin A4 analogues, was selected through docking experiments, synthesized and tested for their anti-proliferative activity against the colon cancer SW48 cell line. These molecules, through the formation of amide bonds in position 3, allow the synthesis of various derivatives that can modulate the activity with great resistance to hydrolytic conditions. The cyclization to obtain the 3-aminoazetidinone ring is highly diastereoselective and provides a trans biologically active isomer under mild reaction conditions with better yields than the 3-hydroxy-2-azetidinone synthesis. All compounds showed IC50 values ranging between 14.0 and 564.2 nM, and the most active compound showed inhibitory activity against tubulin polymerization in vitro, being a potential therapeutic agent against colon cancer.
- 9 May 2016
- Published by Wiley in Archiv der Pharmazie
- Vol. 349 (6) , 414-427
Synthesis of Resveratrol Derivatives and In Vitro Screening for Potential Cancer Chemopreventive Activities
New resveratrol (trans‐3,4’,5‐trihydroxystilbene) analogs were synthesized and screened for their in vitro cancer chemopreventive potential using various bioassays relevant for the prevention of carcinogenesis in humans: two assays to detect modulators of carcinogen metabolism (Cyp1A inhibition; determination of NAD(P)H/quinone reductase (QR) activity), three assays to identify radical scavenging and antioxidant properties (DPPH, ORAC, superoxide anion radicals in differentiated HL‐60 cells), four assays to determine anti‐inflammatory and anti‐hormonal effects (iNOS, Cox‐1 and aromatase inhibition, anti‐estrogenic potential). 3,4′,5‐Tri‐O‐methyl resveratrol 1a was about sevenfold more active than resveratrol in inhibiting Cyp1A activity, it was a potent inducer of QR activity, and it showed pure anti‐estrogenic activity (whereas resveratrol is a known mixed estrogen (ant)agonist with both estrogenic and anti‐estrogenic properties). Dual estrogen ant‐/agonist activity was restored in the mono‐O‐benzyl‐substituted derivatives 4b (4′‐O‐benzyl resveratrol) and 5b (3‐O‐benzyl resveratrol). With respect to aromatase inhibition (Cyp19), which provided the highest number of actives, the benzyl‐substituted series was more potent than the methyl‐substituted derivatives of resveratrol, and 3‐O‐benzyl resveratrol 5b was about eightfold more active than resveratrol. Overall, 3,4′,5‐tri‐O‐pivaloyl resveratrol oxide 7c was identified as a potent inducer of phase 2 enzymes concomitant with inhibition of LPS‐mediated iNOS induction.
- 9 May 2016
- Published by Wiley in Archiv der Pharmazie
- Vol. 349 (6) , 414-427
Synthesis of Resveratrol Derivatives and In Vitro Screening for Potential Cancer Chemopreventive Activities
New resveratrol (trans‐3,4’,5‐trihydroxystilbene) analogs were synthesized and screened for their in vitro cancer chemopreventive potential using various bioassays relevant for the prevention of carcinogenesis in humans: two assays to detect modulators of carcinogen metabolism (Cyp1A inhibition; determination of NAD(P)H/quinone reductase (QR) activity), three assays to identify radical scavenging and antioxidant properties (DPPH, ORAC, superoxide anion radicals in differentiated HL‐60 cells), four assays to determine anti‐inflammatory and anti‐hormonal effects (iNOS, Cox‐1 and aromatase inhibition, anti‐estrogenic potential). 3,4′,5‐Tri‐O‐methyl resveratrol 1a was about sevenfold more active than resveratrol in inhibiting Cyp1A activity, it was a potent inducer of QR activity, and it showed pure anti‐estrogenic activity (whereas resveratrol is a known mixed estrogen (ant)agonist with both estrogenic and anti‐estrogenic properties). Dual estrogen ant‐/agonist activity was restored in the mono‐O‐benzyl‐substituted derivatives 4b (4′‐O‐benzyl resveratrol) and 5b (3‐O‐benzyl resveratrol). With respect to aromatase inhibition (Cyp19), which provided the highest number of actives, the benzyl‐substituted series was more potent than the methyl‐substituted derivatives of resveratrol, and 3‐O‐benzyl resveratrol 5b was about eightfold more active than resveratrol. Overall, 3,4′,5‐tri‐O‐pivaloyl resveratrol oxide 7c was identified as a potent inducer of phase 2 enzymes concomitant with inhibition of LPS‐mediated iNOS induction.
- 19 August 2014
- Published by Springer Nature in Investigational New Drugs
- Vol. 32 (6) , 1123-1133
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer
The anticancer activity of a novel pure 1,4-Diaryl-2-azetidinone (1), endowed with a higher solubility than the well known Combretastatin A4, is tested in mice. We previously reported that Compound (1) showed specific antiproliferative activity against duodenal and colon cancer cells, inducing activation of AMP-activated protein kinase and apoptosis. Here we estimate that the maximum tolerated dose in a mouse model is 40 mg/kg; the drug is well tolerated both in single dose and in repeated administration schedules. The drug displays a significant antitumor activity and a tumor growth delay when administered at the MTD both in single and fractionated i.v. administration in a mouse xenograft model of colorectal cancer. Arrest of tumor growth and relapse after drug suspension are parallel to modification in glucose demand as shown by PET studies with [18 F] FDG. These data strongly support Compound (1) as a promising molecule for in vivo treatment of colorectal cancer.
- 19 August 2014
- Published by Springer Nature in Investigational New Drugs
- Vol. 32 (6) , 1123-1133
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer
The anticancer activity of a novel pure 1,4-Diaryl-2-azetidinone (1), endowed with a higher solubility than the well known Combretastatin A4, is tested in mice. We previously reported that Compound (1) showed specific antiproliferative activity against duodenal and colon cancer cells, inducing activation of AMP-activated protein kinase and apoptosis. Here we estimate that the maximum tolerated dose in a mouse model is 40 mg/kg; the drug is well tolerated both in single dose and in repeated administration schedules. The drug displays a significant antitumor activity and a tumor growth delay when administered at the MTD both in single and fractionated i.v. administration in a mouse xenograft model of colorectal cancer. Arrest of tumor growth and relapse after drug suspension are parallel to modification in glucose demand as shown by PET studies with [18 F] FDG. These data strongly support Compound (1) as a promising molecule for in vivo treatment of colorectal cancer.
- 22 February 2012
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (5) , 2112-2124
Synthesis and Biological Evaluation of 1,4-Diaryl-2-azetidinones as Specific Anticancer Agents: Activation of Adenosine Monophosphate Activated Protein Kinase and Induction of Apoptosis
A series of novel 1,4-diaryl-2-azetidinones were synthesized and evaluated for antiproliferative activity, cell cycle effects, and apoptosis induction. Strong cytotoxicity was observed with the best compounds (±)-trans-20, (±)-trans-21, and enantiomers (+)-trans-20 and (+)-trans-21, which exhibited IC50 values of 3–13 nM against duodenal adenocarcinoma cells. They induced inhibition of tubulin polymerization and subsequent G2/M arrest. This effect was accompanied by activation of AMP-activated protein kinase (AMPK), activation of caspase-3, and induction of apoptosis. Additionally, the most potent compounds displayed antiproliferative activity against different colon cancer cell lines, opening the route to a new class of potential therapeutic agents against colon cancer.
- 22 February 2012
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (5) , 2112-2124
Synthesis and Biological Evaluation of 1,4-Diaryl-2-azetidinones as Specific Anticancer Agents: Activation of Adenosine Monophosphate Activated Protein Kinase and Induction of Apoptosis
A series of novel 1,4-diaryl-2-azetidinones were synthesized and evaluated for antiproliferative activity, cell cycle effects, and apoptosis induction. Strong cytotoxicity was observed with the best compounds (±)-trans-20, (±)-trans-21, and enantiomers (+)-trans-20 and (+)-trans-21, which exhibited IC50 values of 3–13 nM against duodenal adenocarcinoma cells. They induced inhibition of tubulin polymerization and subsequent G2/M arrest. This effect was accompanied by activation of AMP-activated protein kinase (AMPK), activation of caspase-3, and induction of apoptosis. Additionally, the most potent compounds displayed antiproliferative activity against different colon cancer cell lines, opening the route to a new class of potential therapeutic agents against colon cancer.
- 1 August 2010
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 21 (15) , 1885-1889
Multienzymatic preparation of 3-[(1R)-1-hydroxyethyl]benzoic acid and (2S)-hydroxy(phenyl)ethanoic acid
- 1 August 2010
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 21 (15) , 1885-1889
Multienzymatic preparation of 3-[(1R)-1-hydroxyethyl]benzoic acid and (2S)-hydroxy(phenyl)ethanoic acid
- 1 May 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (9) , 2780-2784
Synthesis and biological evaluation of combretastatin analogs as cell cycle inhibitors of the G1 to S transition in Saccharomyces cerevisiae
- 1 May 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (9) , 2780-2784
Synthesis and biological evaluation of combretastatin analogs as cell cycle inhibitors of the G1 to S transition in Saccharomyces cerevisiae
- Top Cited Papers
- 1 January 2010
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 17 (3) , 264-289
Aminophosphonic Acids and Derivatives. Synthesis and Biological Applications
In recent years, phosphonic acids and their derivatives have received increasing attention as analogues of a series of naturally occurring phosphates and as “bio-isosteric phosphorus analogues” of aminoacids. Unlike a phosphate group, the phosphonate moiety is not readily hydrolyzed, in a biological environment, by the enzymes involved in the phosphate cleavage. This feature makes these compounds extremely useful in several applications, in metabolic regulation, in enhancement or inhibition studies, in the development of potential drugs against several metabolic disorders. The great potential of these compounds in biological applications resulted in an intense effort directed to the development of efficient synthetic methods for their preparation, with particular attention to stereoselective synthesis. The purpose of this review is to give an up-to-date account of the chemistry, the synthesis and the biological activity of aminophosphonic acids and their derivatives.
- 1 January 2010
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 17 (3) , 264-289
Top Cited PapersAminophosphonic Acids and Derivatives. Synthesis and Biological Applications
In recent years, phosphonic acids and their derivatives have received increasing attention as analogues of a series of naturally occurring phosphates and as “bio-isosteric phosphorus analogues” of aminoacids. Unlike a phosphate group, the phosphonate moiety is not readily hydrolyzed, in a biological environment, by the enzymes involved in the phosphate cleavage. This feature makes these compounds extremely useful in several applications, in metabolic regulation, in enhancement or inhibition studies, in the development of potential drugs against several metabolic disorders. The great potential of these compounds in biological applications resulted in an intense effort directed to the development of efficient synthetic methods for their preparation, with particular attention to stereoselective synthesis. The purpose of this review is to give an up-to-date account of the chemistry, the synthesis and the biological activity of aminophosphonic acids and their derivatives.
- 1 September 2009
- Published by Elsevier in New Biotechnology
- Vol. 25, S112
Use of oxidoreductive enzymes in sequential biotransformations
- 1 September 2009
- Published by Elsevier in New Biotechnology
- Vol. 25, S112
Use of oxidoreductive enzymes in sequential biotransformations
- 13 May 2009
- Published by Taylor & Francis in Synthetic Communications
- Vol. 39 (12) , 2178-2195
One-Pot, Fluoride-Promoted Wittig Reaction
A one-pot, fluoride-promoted Wittig reaction was developed. The reactions of ethyl α-bromoacetate with aliphatic, aromatic, and heteroaromatic aldehydes in the presence of tri-n-butylphosphine and tetrabutylammonium fluoride produced α,β-unsaturated esters in good to excellent yields and E-stereoselectivity. Under the same conditions, reactions of ethyl α-bromopropionate, α-bromo acetonitrile, and α-bromoacetophenone with aliphatic and aromatic aldehydes in the presence of tri-n-butylphosphine and tetrabutylammonium fluoride produced the expected α,β-unsaturated derivatives in good E-stereoselectivity. The protocol was extended to semistabilized ylides and applied to the synthesis of some combretastatin analogs.
- 13 May 2009
- Published by Taylor & Francis in Synthetic Communications
- Vol. 39 (12) , 2178-2195
One-Pot, Fluoride-Promoted Wittig Reaction
A one-pot, fluoride-promoted Wittig reaction was developed. The reactions of ethyl α-bromoacetate with aliphatic, aromatic, and heteroaromatic aldehydes in the presence of tri-n-butylphosphine and tetrabutylammonium fluoride produced α,β-unsaturated esters in good to excellent yields and E-stereoselectivity. Under the same conditions, reactions of ethyl α-bromopropionate, α-bromo acetonitrile, and α-bromoacetophenone with aliphatic and aromatic aldehydes in the presence of tri-n-butylphosphine and tetrabutylammonium fluoride produced the expected α,β-unsaturated derivatives in good E-stereoselectivity. The protocol was extended to semistabilized ylides and applied to the synthesis of some combretastatin analogs.
- 25 March 2009
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 20 (5) , 563-565
Multienzymatic preparation of (−)-[3-(oxiran-2-yl)phenyl]methanol and (−)-3-(oxiran-2-yl)benzoic acid
- 25 March 2009
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 20 (5) , 563-565
Multienzymatic preparation of (−)-[3-(oxiran-2-yl)phenyl]methanol and (−)-3-(oxiran-2-yl)benzoic acid